SUPERNUS PHARMACEUTICALS, INC. (SUPN) Capital expenditures 2016–2025
SUPERNUS PHARMACEUTICALS, INC. (SUPN) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$1.3MFY2025 · since FY2016: $1.6M → $1.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.3M | +84.6% |
| FY2024 | $725,000 | +31.6% |
| FY2023 | $551,000 | +33.7% |
| FY2022 | $412,000 | — |
| FY2020 | $3.4M | +26.1% |
| FY2019 | $2.7M | +224.2% |
| FY2018 | $844,000 | -58.4% |
| FY2017 | $2.0M | +26.6% |
| FY2016 | $1.6M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice